Biotech. It's a simple, three-syllable word, but it's all it takes to get Rajiv Kaul pumped up.

Biotechnology not only saves lives. It can make for a lucrative investment, says Kaul, the portfolio manager of Fidelity Advisor Biotechnology Fund.

Register or login for access to this item and much more

All Bank Investment Consultant content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access